Beier P, Reese S, Holler P J, Simak J, Tater G, Wess G
Clinic of Small Animal Medicine, University of Munich, Munich, Germany.
J Vet Intern Med. 2015 Jan;29(1):141-9. doi: 10.1111/jvim.12476. Epub 2014 Oct 10.
Hypothyroidism and dilated cardiomyopathy (DCM) are both common diseases in Doberman Pinschers. A possible influence of hypothyroidism on the etiology and progression of DCM is controversial.
Evaluation of the role of hypothyroidism in etiology and progression of DCM.
A total of 175 Doberman Pinschers.
In this longitudinal prospective study, echocardiography and 24-hour ambulatory ECG recordings were performed in all dogs as screening tests for DCM. Total thyroxine (TT4 ) and thyroid ultrasonography served as initial screening tests for hypothyroidism and low TT4 values were followed up by a thyroid stimulating hormone (TSH) test or free total thyroxine (fT4 )/cTSH measurements. Additionally, a follow-up study of dogs affected by both DCM and hypothyroidism under optimal treatment for hypothyroidism was conducted.
A total of 107 dogs were healthy, 45 dogs had DCM, 11 hypothyroidism, and 12 dogs had both DCM and hypothyroidism. TT4 values as well as the thyroid volumes were equivalent in the healthy dogs and in those with DCM. Neither ventricular premature complexes nor echocardiographic parameters differed between healthy and hypothyroid dogs. Dogs with DCM had a 2.26-fold (CI0.95 = 1.1-4.8) higher risk of also being affected by hypothyroidism. Despite optimal thyroid treatment of dogs with hypothyroidism and DCM, there was a progression of the heart disease.
This study did not confirm a role of hypothyroidism in the etiology or progression of DCM. Treatment of hypothyroidism did not improve the clinical outcome.
甲状腺功能减退症和扩张型心肌病(DCM)在杜宾犬中都是常见疾病。甲状腺功能减退症对DCM病因和进展的可能影响存在争议。
评估甲状腺功能减退症在DCM病因和进展中的作用。
总共175只杜宾犬。
在这项纵向前瞻性研究中,对所有犬只进行超声心动图和24小时动态心电图记录,作为DCM的筛查测试。总甲状腺素(TT4)和甲状腺超声检查作为甲状腺功能减退症的初始筛查测试,TT4值较低时通过促甲状腺激素(TSH)测试或游离总甲状腺素(fT4)/犬促甲状腺激素(cTSH)测量进行随访。此外,对同时患有DCM和甲状腺功能减退症的犬只在接受甲状腺功能减退症最佳治疗的情况下进行了随访研究。
共有107只犬健康,45只犬患有DCM,11只犬患有甲状腺功能减退症,12只犬同时患有DCM和甲状腺功能减退症。健康犬和患有DCM的犬的TT4值以及甲状腺体积相当。健康犬和甲状腺功能减退犬的室性早搏复合体和超声心动图参数均无差异。患有DCM的犬患甲状腺功能减退症的风险高2.26倍(CI0.95 = 1.1 - 4.8)。尽管对患有甲状腺功能减退症和DCM的犬进行了最佳甲状腺治疗,但心脏病仍有进展。
本研究未证实甲状腺功能减退症在DCM病因或进展中的作用。甲状腺功能减退症的治疗并未改善临床结局。